Public health in the Dominican Republic will be reinforced thanks to the implementation of the National Post-Commercialization Surveillance Project of Medications Containing Controlled Substances, a joint initiative between the National Directorate of Drug Control (DNCD) and the General Directorate of Medications, Foods and Health Products (DIGEMAPS). This project aims to protect public health and ensure the efficacy of controlled medications throughout the national territory. The action focuses on consolidating monitoring and oversight mechanisms along the entire supply chain, from importation and manufacturing to distribution, dispensing, and final use, through a coordinated effort with regulated pharmaceutical sector actors.
Controlled Medication Surveillance
The initiative acquires strategic relevance in the face of situations related to mental health and the consumption of medications under surveillance, focusing protection actions prioritarily in communities and individuals in a situation of susceptibility. As part of the project’s execution, accredited inspectors will conduct visits to selected establishments for the collection of samples and data, following rigorous technical protocols. The collected samples will be transferred and inspected at the Human Consumer Products Evaluation Laboratory, where they will be subjected to analysis under strict scientific and quality standards.
Collaboration and Regulation
The institutions made an active call for the collaboration of the commercial and establishment sector of the pharmaceutical industry, emphasizing that their participation is key to strengthening public policies, sanitary regulation, and the integral protection of the Dominican population. This initiative develops within the institutional competences of both entities and the coordination mechanisms for the strengthening of public health. Decree No. 231-23, dated June 5, 2023, grants DIGEMAPS the condition of an organ with functional, administrative, and financial decentralization of the Ministry of Public Health, strengthening its institutional capacity in matters of regulation and sanitary surveillance.
The implementation of this project reflects the authorities’ commitment to public health protection and the effective regulation of controlled medications in the Dominican Republic. The collaboration between the involved institutions and the pharmaceutical sector is fundamental for the success of this initiative and to ensure that the medications reaching citizens are safe and effective.
Credits: n.com.do
Note generated automatically from the sources cited in the text. Found an error? Email us at [email protected] and we'll fix it.
